These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 8132777)

  • 41. Antibodies to HIV-1 nef(p27): prevalence, significance, and relationship to seroconversion.
    Cheingsong-Popov R; Panagiotidi C; Ali M; Bowcock S; Watkins P; Aronstam A; Wassef M; Weber J
    AIDS Res Hum Retroviruses; 1990 Sep; 6(9):1099-105. PubMed ID: 2265027
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antibodies to recombinant HIV-1 nef protein detected in HIV-1 infection as well as in nonrisk individuals.
    Ranki A; Järvinen K; Valle SL; Nurmilaakso P; Krohn K
    J Acquir Immune Defic Syndr (1988); 1990; 3(4):348-55. PubMed ID: 2179525
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relevance of anti-nef antibody detection as an early serologic marker of human immunodeficiency virus infection.
    Bahraoui E; Benjouad A; Sabatier JM; Allain JP; Laurian Y; Montagnier L; Gluckman JC
    Blood; 1990 Jul; 76(1):257-64. PubMed ID: 1694699
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antigenic epitopes of NEF proteins from different HIV-1 strains as recognized by sera from patients with manifest and latent HIV infection.
    Gombert FO; Blecha W; Tähtinen M; Ranki A; Pfeifer S; Tröger W; Braun R; Müller-Lantzsch N; Jung G; Rübsamen-Waigmann H
    Virology; 1990 Jun; 176(2):458-66. PubMed ID: 1693246
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1.
    Clerici M; Giorgi JV; Chou CC; Gudeman VK; Zack JA; Gupta P; Ho HN; Nishanian PG; Berzofsky JA; Shearer GM
    J Infect Dis; 1992 Jun; 165(6):1012-9. PubMed ID: 1533867
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of live-attenuated and whole-inactivated simian immunodeficiency virus vaccines against vaginal challenge with virulent SIV.
    Marthas ML; Miller CJ; Sutjipto S; Higgins J; Torten J; Lohman BL; Unger RE; Ramos RA; Kiyono H; McGhee JR
    J Med Primatol; 1992; 21(2-3):99-107. PubMed ID: 1433273
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Silent human immunodeficiency virus type 1 infection: a rare occurrence in a high-risk heterosexual population.
    Brettler DB; Somasundaran M; Forsberg AF; Krause E; Sullivan JL
    Blood; 1992 Nov; 80(9):2396-400. PubMed ID: 1421411
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cytotoxic T lymphocyte responses in the peripheral blood of children born to human immunodeficiency virus-1-infected mothers.
    Cheynier R; Langlade-Demoyen P; Marescot MR; Blanche S; Blondin G; Wain-Hobson S; Griscelli C; Vilmer E; Plata F
    Eur J Immunol; 1992 Sep; 22(9):2211-7. PubMed ID: 1381309
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immune responses to human immunodeficiency virus type 1 in exposed but uninfected individuals: protection or chance?
    Looney DJ
    J Clin Invest; 1994 Mar; 93(3):920. PubMed ID: 8132777
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.